Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Dapagliflozin propanediol by AstraZeneca for Diastolic Heart Failure (HFpEF): Likelihood of Approval
Dapagliflozin propanediol is under clinical development by AstraZeneca and currently in Phase III for Diastolic Heart Failure (HFpEF). According to...